Pneumonia vaccine acceptance study in Panama
Part of Immune system & allergy, Infections clinical trials.
This study looks at how willing older adults in Panama and their caregivers are to get a pneumonia vaccine. It may help improve vaccination programs for older people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- You live in Panama, in a city, town, or rural area.
- You have access to healthcare through public or private systems.
- You can speak Spanish or have an interpreter available.
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral polio vaccine in children and babies in Panama. The goal is to see if it is safe and helps the body build protection against polio.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This study is looking at how age affects the immune system's response to a pneumococcal vaccine. Researchers want to compare younger and older adults to see if immune cells change with age.
This trial tests whether a pneumococcal vaccine can help protect against a specific type of pneumonia bacteria. Researchers want to see if the vaccine can create antibodies that work against multiple strains.
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
Hear when a new Pneumococcal Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.